These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 150804)

  • 1. Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):313-8. PubMed ID: 150804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of intercompartmental disposition and excretion of tubocurarine, gallamine, alcuronium and pancuronium in patients with normal and impaired renal function.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):319-21. PubMed ID: 150805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative potency of some neuromuscular blocking drugs in vivo and in vitro.
    Anttila P; Ertama P
    Med Biol; 1978 Jun; 56(3):152-5. PubMed ID: 682698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five non-depolarizing muscle relaxants in precurarization.
    Erkola O; Salmenperä A; Kuoppamäki R
    Acta Anaesthesiol Scand; 1983 Dec; 27(6):427-32. PubMed ID: 6141695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.
    Nedoma J; Dorofeeva NA; Tucek S; Shelkovnikov SA; Danilov AF
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):176-81. PubMed ID: 4010794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
    Glisson SN; Sanchez MM; El-Etr AA; Lim RA
    Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response curves for four neuromuscular blockers using continuous i.v. infusion.
    Shanks CA; Walker JS; Ramzan MI; Triggs EJ
    Br J Anaesth; 1981 Jun; 53(6):627-33. PubMed ID: 7248126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Feb; 48(2):59-68. PubMed ID: 130154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?
    Kopman AF
    Anesthesiology; 1989 Jun; 70(6):915-20. PubMed ID: 2729631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine liberation in surgical patients following administration of neuromuscular blocking drugs.
    Ertama PM
    Ann Clin Res; 1982 Feb; 14(1):15-26. PubMed ID: 6182834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-lasting neuromuscular effects of non-depolarizing muscle relaxants, as measured by tetanic stimulation (author's transl)].
    Barth L; Dannhorn R
    Anaesthesist; 1977 Mar; 26(3):116-24. PubMed ID: 857690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency and onset of action of neuromuscular blocking drugs.
    Wierda JM; van den Broek L; Schiere S; Maestrone E
    Anesth Analg; 1995 Jun; 80(6):1249-50. PubMed ID: 7762863
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscle relaxant drugs.
    Thompson MA
    Br J Hosp Med; 1980 Feb; 23(2):153-4, 163-4, 167-8 passim. PubMed ID: 6102875
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of prior administration of suxamethonium on non-depolarising muscle relaxants in the dog.
    Jones RS; Gleed RD
    Res Vet Sci; 1984 Jan; 36(1):43-7. PubMed ID: 6709976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histamine-N-methyltransferase activity by neuromuscular blocking drugs.
    Harle DG; Baldo BA; Fisher MM
    Agents Actions; 1985 Oct; 17(1):27-31. PubMed ID: 4083176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children.
    Goudsouzian NG; Martyn JJ; Liu LM; Ali HH
    Can Anaesth Soc J; 1984 May; 31(3 Pt 1):246-50. PubMed ID: 6722619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of muscle relaxants in clinical use.
    Ertama P; Mäkeläinen A
    Ann Chir Gynaecol; 1977; 66(2):113-9. PubMed ID: 141237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation.
    Pollard BJ; Jones RM
    Br J Anaesth; 1983 Nov; 55(11):1127-31. PubMed ID: 6315037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of neuromuscular blocking agents on arterial blood pressure in the rat.
    Jiffry MT
    Indian J Physiol Pharmacol; 1979; 23(2):133-6. PubMed ID: 489095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.